ArtritoMabTM Antibody Cocktail voor Balb/c, DBA/1, R10.RIII
Gecertificeerd

ArtritoMabTM Antibody Cocktail voor Balb/c, DBA/1, R10.RIII

Catalog #: CIA-MAB-50
Maat: 50 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

ArthritoMabTM Arthritis Inducing Antibody Cocktail is a cocktail of 4 arthritogenic monoclonal antibodies to collagen II (CII) used for inducing arthritis in the anti-Collagen Antibody Induced Arthritis (CAIA) model. It is an excellent alternative to both the K/BxN and CIA models. Induction is rapid and results in a synchronized, steady and controlled disease progression that exhibits histological similarities to the classic CIA model. Download a protocol guide and data pack to learn more about the epitopes, protocol, optimization tips, positive controls and data. The Collagen Antibody Induced Arthritis (CAIA) model is a relevant model for studying the efferent phase of RA, where leukocytes are attracted and respond to the immune complex in the joint. It is induced using a cocktail of antibodies to anti-CII and contains pathogenic features similar to that of RA such as pannus formation, cellular infiltration, synovitis and cartilage/bone destruction. Download the whitepaper For use with C57BL/6, TG strains, see ArthritoMabTM Antibody Cocktail for C57BL/6, TG, 50 mg . Figure: Balb/c were administered 2 mg of ArthritoMab antibody cocktail on day 0 followed by a LPS boost on day 3. Unlike competitor products, disease progression is steady and controlled for easy evaluation of prophylactic and therapeutic regimes. Benefits of the CAIA model Length of study: Arthritis develops in mice typically within 24-48 hr allowing the completion of a study within 2 weeks reducing the number of assessments and scoring periods. Reduced group size: Rate of incidence is nearly 100% depending on the strain allowing for smaller group sizes. Synchronization: onset of disease is synchronized between animals simplifying treatment schedules. Steady & Controlled disease progression: No rapid & severe disease spikes enabling evaluation of all treatment schedules Susceptibility: Arthritis is induced not only in CIA-susceptible DBA/1 and B10.RIII mice, but also in some CIA-resistant mice, such as Balb/c. Eliminates expensive colonies: Models such as the K/BxN serum transfer model require labs to maintain expensive colonies and the sera can vary from batch to batch. Comparison ArthritoMabTM Competitor Epitopes Recognized CB11, CB10, CB8 CB11 only Disease Progression Steady & Controlled Rapid & Severe Paw involvement Consistent & Predominantely rear Variable & unpredictable Animals/vial 25 20 Abreviations: Anti-Collagen Induced arthritis (ACIA) Monoclonal Antibody induced arthritis (mAb-RA) Collagen Antibody Induced Arthritis (CAIA)

Description

ArthritoMabTM Arthritis Inducing Antibody Cocktail is a cocktail of 4 arthritogenic monoclonal antibodies to collagen II (CII) used for inducing arthritis in the anti-Collagen Antibody Induced Arthritis (CAIA) model. It is...

Short Description

ArthritoMabTM Antibody Cocktail for Balb/c, DBA/1, R10.RIII, 50 mg

Assay Type

Antibodies

Beschrijving

ArthritoMabTM Arthritis Inducing Antibody Cocktail is a cocktail of 4 arthritogenic monoclonal antibodies to collagen II (CII) used for inducing arthritis in th

Specificaties

ProductnaamArtritoMabTM Antibody Cocktail voor Balb/c, DBA/1, R10.RIII
Categorie
Beschikbare grootte50 mg
CatalogusnummerCIA-MAB-50